Clinical observation of liver chemistry abnormalities in asthmatics

Current Drug Safety

Volumn 4, Issue 3, 2009, Pages 173-180

  Katz, David A ^a   Isaacson, Jeffrey D ^a,b   Han, Lixin ^a,c   Drajesk, Jeffrey F ^a   Comer, Gail M ^a,c   Heath Chiozzi, Margo E ^a,d  

^a ABBOTT LABORATORIES   (United States)

^b WebbWrites LLC   (United States)

^c PFIZER INC   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

Alanine aminotransferase; Alkaline phosphatase; Aspartate aminotransferase; Bilirubin; Gamma glutaminyl transferase; Observational study

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BILIRUBIN; COTRIMOXAZOLE; GAMMA GLUTAMYLTRANSFERASE; NEDOCROMIL; NITROFURANTOIN; STEROID; XANTHINE DERIVATIVE; ZILEUTON; ANTIASTHMATIC AGENT; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHMA; BILIRUBIN BLOOD LEVEL; CLINICAL OBSERVATION; FEMALE; HEPATITIS; HUMAN; INCIDENCE; JAUNDICE; LIVER CELL DAMAGE; LIVER DISEASE; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; SIDE EFFECT; BLOOD; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; HOSPITALIZATION; LIVER; MIDDLE AGED; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME; TOXIC HEPATITIS;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANTI-ASTHMATIC AGENTS; ASPARTATE AMINOTRANSFERASES; ASTHMA; BILIRUBIN; BIOLOGICAL MARKERS; DRUG-INDUCED LIVER INJURY; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 73349094092     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488609789006930     Document Type: Article

References (14)

1. Rosenzweig P, Miget N, Brohier S. Transaminase elevation on placebo during Phase I trials: prevalence and significance. Br J Clin Pharmacol 1999; 48: 19-23.
2. Pederson T, Berg K, Cook T, et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the scandinavian simvastatin survival study. Arch Int Med 1996; 156: 2085-92.
3. Chapman KR, Ljungholm K, Kallen A, et al. Long-term xanthine therapy of asthma. Chest 1994;106: 1407-13
4. Pratt D, Kaplan M. Primary care: evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342(17): 1266-71.
5. Zimmerman H. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott Williams & Wilkins 1999.
6. Temple R. Hepatotoxicity Through the Years: Impact on the FDA. 〈http://www.fda.gov/cder/livertox/meeting2001.htm#Drug-Induced〉, 2001.
7. Colldahl H. A study of serum enzymes in patients suffering from periods of respiratory: insufficiency, especially asthma and emphysema. Acta Med Scand 1960; 166: 399-400.
8. Refsum HE. Arterial hypoxemia, serum activities of GO-T, GP-T and LDH, and centrilobular liver cell necrosis in pulmonary insufficiency. Clin Sci 1963; 25(3): 69-74.
9. Colldahl H. Serum enzymes in patients with asthma and emphysema. Acta Allergolog 1964; 19: 97-102.
10. El-Shaboury AH, Thomas AJ, Williams DA. Serum tansaminase activity in status asthmaticus. Br Med J 1964; 1: 1220-3.
11. Sundberg M, Ahlqvist J, Kotovirta M-L. Serum transaminase activity and liver alterations in bronchial asthma. Acta Allergolog 1968; 23: 54-68.
12. Samaria JK, Roy DC, Agarwal BV, Matah SC. Profile of serum transaminases in acute bronchial asthma. Ind J Chest Dis Sci 1986; 28: 63-5.
13. Wald JA, Farr RS. Abnormal liver-function tests associated with long-term systemic corticosteroid use in subjects with asthma. J Allergy Clin Immunol 1991; 88: 277-8.
14. Iribarren C, Sidney S, Lydick E, et al. The association between asthma, asthma therapeutic classes and hepatic enzyme elevation among adult HMO members. Comp Ther 2001; 27: 133-9.